*Autoimmune Diseases of the GI Tract Part I: Etiology and Pathophysiology DOI: http://dx.doi.org/10.5772/intechopen.106184*

[55] Pandolfino JE, Gawron AJ. Achalasia: A systematic review. Journal of the American Medical Association. 2015;**313**(18):1841-1852. DOI: 10.1001/ jama.2015.2996

[56] Castagliuolo I, Brun P, Costantini M, Rizzetto C, Palù G, Costantino M, et al. Esophageal achalasia: Is the herpes simplex virus really innocent? Journal of Gastrointestinal Surgery. 2004;**8**(1):24- 30; discussion 30. DOI: 10.1016/j. gassur.2003.10.004

[57] Facco M, Brun P, Baesso I, Costantini M, Rizzetto C, Berto A, et al. T cells in the myenteric plexus of achalasia patients show a skewed TCR repertoire and react to HSV-1 antigens. The American Journal of Gastroenterology. 2008;**103**(7):1598- 1609. DOI: 10.1111/j.1572-0241. 2008.01956.x

[58] Boeckxstaens GE, Zaninotto G, Richter JE. Achalasia. Lancet. 2014;**383**(9911):83-93. DOI: 10.1016/ S0140-6736(13)60651-0

[59] Boeckxstaens GE. Achalasia: Virusinduced euthanasia of neurons? The American Journal of Gastroenterology. 2008;**103**(7):1610-1612. DOI: 10.1111/ j.1572-0241.2008.01967.x

[60] Spechler SJ, Konda V, Souza R. Can eosinophilic esophagitis cause achalasia and other esophageal motility disorders? The American Journal of Gastroenterology. 2018;**113**(11):1594- 1599. DOI: 10.1038/s41395-018-0240-3

[61] Nuñez C, García-González MA, Santiago JL, Benito MS, Mearín F, de la Concha EG, et al. Association of IL10 promoter polymorphisms with idiopathic achalasia. Human Immunology. 2011;**72**(9):749-752. DOI: 10.1016/j. humimm.2011.05.017

[62] de León AR, de la Serna JP, Santiago JL, Sevilla C, Fernández-Arquero M, de la Concha EG, et al. Association between idiopathic achalasia and IL23R gene. Neurogastroenterology and Motility. 2010;**22**(7):734-738, e218. DOI: 10.1111/j.1365-2982.2010.01497.x

[63] Pressman A, Behar J. Etiology and pathogenesis of idiopathic achalasia. Journal of Clinical Gastroenterology. 2017;**51**(3):195-202. DOI: 10.1097/ MCG.0000000000000780

[64] Palmieri O, Mazza T, Merla A, Fusilli C, Cuttitta A, Martino G, et al. Gene expression of muscular and neuronal pathways is cooperatively dysregulated in patients with idiopathic achalasia. Scientific Reports. 2016;**6**:31549. DOI: 10.1038/srep31549

[65] Alahdab YO, Eren F, Giral A, Gunduz F, Kedrah AE, Atug O, et al. Preliminary evidence of an association between the functional c-kit rs6554199 polymorphism and achalasia in a Turkish population. Neurogastroenterology and Motility. 2012;**24**(1):27-30. Available from: https://onlinelibrary.wiley.com/ doi/10.1111/j.1365-2982.2011.01793.x

[66] Aggestrup S, Uddman R, Sundler F, Fahrenkrug J, Håkanson R, Sørensen HR, et al. Lack of vasoactive intestinal polypeptide nerves in esophageal achalasia. Gastroenterology. 1983;**84**(5 Pt 1):924-927. Available from: https://www. ncbi.nlm.nih.gov/pubmed/6832568

[67] Paladini F, Cocco E, Cascino I, Belfiore F, Badiali D, Piretta L, et al. Age-dependent association of idiopathic achalasia with vasoactive intestinal peptide receptor 1 gene. Neurogastroenterology and Motility. 2009;**21**(6):597-602. Available from: https://onlinelibrary.wiley.com/ doi/10.1111/j.1365-2982.2009.01284.x [68] Samo S, Carlson DA, Gregory DL, Gawel SH, Pandolfino JE, Kahrilas PJ. Incidence and prevalence of achalasia in Central Chicago, 2004-2014, since the widespread use of high-resolution manometry. Clinical Gastroenterology and Hepatology. 2017;**15**(3):366-373. DOI: 10.1016/j.cgh.2016.08.030

[69] Sadowski DC, Ackah F, Jiang B, Svenson LW. Achalasia: Incidence, prevalence and survival. A population-based study. Neurogastroenterology and Motility. 2010;**22**(9):e256-e261. Available from: https://onlinelibrary.wiley.com/ doi/10.1111/j.1365-2982.2010.01511.x

[70] Sonnenberg A. Hospitalization for achalasia in the United States 1997- 2006. Digestive Diseases and Sciences. 2009;**54**(8):1680-1685. DOI: 10.1007/ s10620-009-0863-8

[71] Ng KY, Li KF, Lok KH, Lai L, Ng CH, Li KK, et al. Ten-year review of epidemiology, clinical features, and treatment outcome of achalasia in a regional hospital in Hong Kong. Hong Kong Medical Journal. 2010;**16**(5):362- 366. Available from: https://www.ncbi. nlm.nih.gov/pubmed/20890000

[72] Vantrappen G, Hellemans J, Deloof W, Valembois P, Vandenbroucke J. Treatment of achalasia with pneumatic dilatations. Gut. 1971;**12**(4):268-275. DOI: 10.1136/gut.12.4.268

[73] Richter JE, Boeckxstaens GE. Management of achalasia: Surgery or pneumatic dilation. Gut. 2011;**60**(6): 869-876. DOI: 10.1136/gut.2010.212423

[74] Di Sabatino A, Lenti MV, Giuffrida P, Vanoli A, Corazza GR. New insights into immune mechanisms underlying autoimmune diseases of the gastrointestinal tract. Autoimmunity

Reviews. 2015;**14**(12):1161-1169. DOI: 10.1016/j.autrev.2015.08.004

[75] Massironi S, Zilli A, Elvevi A, Invernizzi P. The changing face of chronic autoimmune atrophic gastritis: An updated comprehensive perspective. Autoimmunity Reviews. 2019;**18**(3):215- 222. DOI: 10.1016/j.autrev.2018.08.011

[76] Miceli E, Vanoli A, Lenti MV, Klersy C, Di Stefano M, Luinetti O, et al. Natural history of autoimmune atrophic gastritis: A prospective, single Centre, long-term experience. Alimentary Pharmacology & Therapeutics. 2019;**50**(11-12):1172-1180. Available from: https://onlinelibrary.wiley.com/ doi/10.1111/apt.15540

[77] Centanni M, Marignani M, Gargano L, Corleto VD, Casini A, Delle Fave G, et al. Atrophic body gastritis in patients with autoimmune thyroid disease: An underdiagnosed association. Archives of Internal Medicine. 1999;**159**(15):1726-1730. DOI: 10.1001/ archinte.159.15.1726

[78] Rugge M, Correa P, Dixon MF, Fiocca R, Hattori T, Lechago J, et al. Gastric mucosal atrophy: Interobserver consistency using new criteria for classification and grading. Alimentary Pharmacology & Therapeutics. 2002;**16**(7):1249-1259. DOI: 10.1046/j.1365-2036.2002.01301.x

[79] Dixon MF, Genta RM, Yardley JH, Correa P. The participants. Classification and grading of gastritis: The updated Sydney system. The American Journal of Surgical Pathology. 1996;**20**(10):1161. Available from: https://journals.lww.com/ ajsp/fulltext/1996/10000/classification\_ and\_grading\_of\_gastritis\_\_the.1.aspx

[80] Neumann WL, Coss E, Rugge M, Genta RM. Autoimmune atrophic

*Autoimmune Diseases of the GI Tract Part I: Etiology and Pathophysiology DOI: http://dx.doi.org/10.5772/intechopen.106184*

gastritis—Pathogenesis, pathology and management. Nature Reviews. Gastroenterology & Hepatology. 2013;**10**(9):529-541. Available from: https://www.nature.com/articles/ nrgastro.2013.101

[81] Rodriguez-Castro KI, Franceschi M, Miraglia C, Russo M, Nouvenne A, Leandro G, et al. Autoimmune diseases in autoimmune atrophic gastritis. Acta Bio-Medica. 2018;**89**(8-S):100-103. Available from: https://www.mattioli1885journals. com/index.php/actabiomedica/article/ view/7919

[82] Lenti MV, Miceli E, Cococcia S, Klersy C, Staiani M, Guglielmi F, et al. Determinants of diagnostic delay in autoimmune atrophic gastritis. Alimentary Pharmacology & Therapeutics. 2019;**50**(2):167-175. DOI: 10.1111/apt.15317

[83] Jacobson DL, Gange SJ, Rose NR, Graham NM. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clinical Immunology and Immunopathology. 1997;**84**(3):223-243. DOI: 10.1006/clin.1997.4412

[84] López-Jornet P, Parra-Perez F, Pons-Fuster A. Association of autoimmune diseases with oral lichen planus: A cross-sectional, clinical study. Journal of the European Academy of Dermatology and Venereology. 2014;**28**(7):895-899. Available from: https://onlinelibrary.wiley.com/ doi/10.1111/jdv.12202

[85] Kanazawa M, Shimohata T, Tanaka K, Nishizawa M. Clinical features of patients with myasthenia gravis associated with autoimmune diseases. European Journal of Neurology. 2007;**14**(12):1403-1404. DOI: 10.1111/j.1468-1331.2007.01978.x

[86] Amerio P, Tracanna M, De Remigis P, Betterle C, Vianale L, Marra ME, et al. Vitiligo associated with other autoimmune diseases: Polyglandular autoimmune syndrome types 3B+C and 4. Clinical and Experimental Dermatology. 2006;**31**(5):746-749. DOI: 10.1111/j.1365-2230.2006.02171.x

[87] De Block CEM, De Leeuw IH, Van Gaal LF. Autoimmune gastritis in type 1 diabetes: A clinically oriented review. The Journal of Clinical Endocrinology and Metabolism. 2008;**93**(2):363-371. DOI: 10.1210/jc.2007-2134

[88] Fallahi P, Ferrari SM, Ruffilli I, Elia G, Biricotti M, Vita R, et al. The association of other autoimmune diseases in patients with autoimmune thyroiditis: Review of the literature and report of a large series of patients. Autoimmunity Reviews. 2016;**15**(12):1125-1128. DOI: 10.1016/j.autrev.2016.09.009

[89] Zelissen PM, Bast EJ, Croughs RJ. Associated autoimmunity in Addison's disease. Journal of Autoimmunity. 1995;**8**(1):121-130. DOI: 10.1006/ jaut.1995.0009

[90] Toh BH, van Driel IR, Gleeson PA. Pernicious anemia. The New England Journal of Medicine. 1997;**337**(20):1441-1448. DOI: 10.1056/ NEJM199711133372007

[91] Vannella L, Lahner E, Osborn J, Annibale B. Systematic review: Gastric cancer incidence in pernicious anaemia. Alimentary Pharmacology & Therapeutics. 2013;**37**(4):375-382. DOI: 10.1111/apt.12177

[92] La Rosa S, Vanoli A. Gastric neuroendocrine neoplasms and related precursor lesions. Journal of Clinical Pathology. 2014;**67**(11):938-948. DOI: 10.1136/jclinpath-2014-202515

[93] Minalyan A, Benhammou JN, Artashesyan A, Lewis MS, Pisegna JR. Autoimmune atrophic gastritis: Current perspectives. Clinical and Experimental Gastroenterology. 2017;**10**:19-27. DOI: 10.2147/CEG.S109123

[94] Oxentenko AS, Rubio-Tapia A. Celiac disease. Mayo Clinic Proceedings. 2019;**94**(12):2556-2571. DOI: 10.1016/j. mayocp.2019.02.019

[95] Ludvigsson JF, Leffler DA, Bai JC, Biagi F, Fasano A, Green PHR, et al. The Oslo definitions for coeliac disease and related terms. Gut. 2013;**62**(1):43-52. Available from: https://gut.bmj.com/cont ent/62/1/43?62/1/43r62/1/43

[96] Hujoel IA, Reilly NR, Rubio-Tapia A. Celiac disease: Clinical features and diagnosis. Gastroenterology Clinics of North America. 2019;**48**(1):19-37. DOI: 10.1016/j.gtc.2018.09.001

[97] Green PHR, Rostami K, Marsh MN. Diagnosis of coeliac disease. Best Practice & Research. Clinical Gastroenterology. 2005;**19**(3):389-400. DOI: 10.1016/j. bpg.2005.02.006

[98] Rubio-Tapia A, Hill ID, Kelly CP, Calderwood AH, Murray JA. American College of Gastroenterology. ACG clinical guidelines: Diagnosis and management of celiac disease. The American Journal of Gastroenterology. 2013;**108**(5):656-676; quiz 677. Available from: https://journals.lww. com/00000434-201305000-00007

[99] Sollid LM, Lie BA. Celiac disease genetics: Current concepts and practical applications. Clinical Gastroenterology and Hepatology. 2005;**3**(9):843-851. DOI: 10.1016/s1542-3565(05)00532-x

[100] Dieli-Crimi R, Cénit MC, Núñez C. The genetics of celiac disease: A comprehensive review of clinical

implications. Journal of Autoimmunity. 2015;**64**:26-41. DOI: 10.1016/j. jaut.2015.07.003

[101] Mazzilli MC, Ferrante P, Mariani P, Martone E, Petronzelli F, Triglione P, et al. A study of Italian pediatric celiac disease patients confirms that the primary HLA association is to the DQ (α1∗ 0501, β1∗ 0201) heterodimer. Human Immunology. 1992;**33**(2):133- 139. Available from: https://www. sciencedirect.com/science/article/ pii/019888599290064T

[102] Fasano A, Catassi C. Clinical practice. Celiac disease. New England Journal of Medicine. 2012;**367**(25):2419- 2426. DOI: 10.1056/NEJMcp1113994

[103] Ludvigsson JF, Rubio-Tapia A, van Dyke CT, Melton LJ 3rd, Zinsmeister AR, Lahr BD, et al. Increasing incidence of celiac disease in a north American population. The American Journal of Gastroenterology. 2013;**108**(5):818-824. DOI: 10.1038/ajg.2013.60

[104] Dominguez Castro P, Harkin G, Hussey M, Christopher B, Kiat C, Liong Chin J, et al. Changes in presentation of celiac disease in Ireland from the 1960s to 2015. Clinical Gastroenterology and Hepatology. 2017;**15**(6):864-871. e3. Available from: https://www. sciencedirect.com/science/article/pii/ S1542356516311168

[105] Schøsler L, Christensen LA, Hvas CL. Symptoms and findings in adult-onset celiac disease in a historical Danish patient cohort. Scandinavian Journal of Gastroenterology. 2016;**51**(3):288-294. DOI: 10.3109/00365521.2015.1092576

[106] Scanlon SA, Murray JA. Update on celiac disease—Etiology, differential diagnosis, drug targets, and management advances. Clinical and Experimental

*Autoimmune Diseases of the GI Tract Part I: Etiology and Pathophysiology DOI: http://dx.doi.org/10.5772/intechopen.106184*

Gastroenterology. 2011;**4**:297-311. DOI: 10.2147/CEG.S8315

[107] Biagi F, Trotta L, Alfano C, Balduzzi D, Staffieri V, Bianchi PI, et al. Prevalence and natural history of potential celiac disease in adult patients. Scandinavian Journal of Gastroenterology. 2013;**48**(5):537-542. DOI: 10.3109/00365521.2013.777470

[108] Rubio-Tapia A, Ludvigsson JF, Brantner TL, Murray JA, Everhart JE. The prevalence of celiac disease in the United States. American Journal of Gastroenterology. 2012;**107**(10):1538- 1544. quiz 1537, 1545. DOI: 10.1038/ ajg.2012.219

[109] Raiteri A, Granito A, Giamperoli A, Catenaro T, Negrini G, Tovoli F. Current guidelines for the management of celiac disease: A systematic review with comparative analysis. World Journal of Gastroenterology. 2022;**28**(1):154-175. DOI: 10.3748/wjg.v28.i1.154

[110] Stern M, Working Group on Serologic Screening for Celiac Disease. Comparative evaluation of serologic tests for celiac disease: A European initiative toward standardization. Journal of Pediatric Gastroenterology and Nutrition. 2000;**31**(5):513-519. DOI: 10.1097/00005176-200011000- 00012

[111] Carroccio A, Vitale G, Di Prima L, Chifari N, Napoli S, La Russa C, et al. Comparison of anti-transglutaminase ELISAs and an anti-endomysial antibody assay in the diagnosis of celiac disease: A prospective study. Clinical Chemistry. 2002;**48**(9):1546-1550. Available from: https://www.ncbi.nlm.nih.gov/ pubmed/12194932

[112] Korponay-Szabó IR, Dahlbom I, Laurila K, Koskinen S, Woolley N, Partanen J, et al. Elevation of

IgG antibodies against tissue transglutaminase as a diagnostic tool for coeliac disease in selective IgA deficiency. Gut. 2003;**52**(11):1567-1571. DOI: 10.1136/gut.52.11.1567

[113] Granito A, Muratori L, Muratori P, Petrolini N, Bianchi FB, Volta U. Antitransglutaminase antibodies and giardiasis. American Journal of Gastroenterology. 2004;**99**(12):2505-2506. DOI: 10.1111/ j.1572-0241.2004.41389\_9.x

[114] Reeves GEM, Squance ML, Duggan AE, Murugasu RR, Wilson RJ, Wong RC, et al. Diagnostic accuracy of coeliac serological tests: A prospective study. European Journal of Gastroenterology & Hepatology. 2006;**18**(5):493-501. DOI: 10.1097/00042737-200605000- 00006

[115] Volta U, Fabbri A, Parisi C, Piscaglia M, Caio G, Tovoli F, et al. Old and new serological tests for celiac disease screening. Expert Review of Gastroenterology & Hepatology. 2010;**4**(1):31-35. DOI: 10.1586/egh.09.66

[116] Sood A, Khurana MS, Mahajan R, Midha V, Puri S, Kaur A, et al. Prevalence and clinical significance of IgA antitissue transglutaminase antibodies in patients with chronic liver disease. Journal of Gastroenterology and Hepatology. 2017;**32**(2):446-450. Available from: https://onlinelibrary. wiley.com/doi/10.1111/jgh.13474

[117] Mozo L, Gómez J, Escanlar E, Bousoño C, Gutiérrez C. Diagnostic value of anti-deamidated gliadin peptide IgG antibodies for celiac disease in children and IgA-deficient patients. Journal of Pediatric Gastroenterology and Nutrition. 2012;**55**(1):50-55. DOI: 10.1097/MPG.0b013e31824703c7

[118] Ludvigsson JF, Bai JC, Biagi F, Card TR, Ciacci C, Ciclitira PJ, et al. Diagnosis and management of adult coeliac disease: Guidelines from the British Society of Gastroenterology. Gut. 2014;**63**(8):1210-1228. DOI: 10.1136/ gutjnl-2013-306578

[119] Liacouras CA, Furuta GT, Hirano I, Atkins D, Attwood SE, Bonis PA, et al. Eosinophilic esophagitis: Updated consensus recommendations for children and adults. Journal of Allergy and Clinical Immunology. 2011;**128**(1): 3-20.e6. quiz 21-2. DOI: 10.1016/j. jaci.2011.02.040

[120] Reed CC, Dellon ES. Eosinophilic esophagitis. The Medical Clinics of North America. 2019;**103**(1):29-42. DOI: 10.1016/j.mcna.2018.08.009

[121] Lucendo AJ, Molina-Infante J, Arias Á, von Arnim U, Bredenoord AJ, Bussmann C, et al. Guidelines on eosinophilic esophagitis: Evidence-based statements and recommendations for diagnosis and management in children and adults. United European Gastroenterology Journal. 2017;**5**(3):335-358. DOI: 10.1177/2050640616689525

[122] Jensen ET, Kappelman MD, Martin CF, Dellon ES. Health-care utilization, costs, and the burden of disease related to eosinophilic esophagitis in the United States. The American Journal of Gastroenterology. 2015;**110**(5):626-632. DOI: 10.1038/ ajg.2014.316

[123] Dellon ES, Hirano I. Epidemiology and natural history of eosinophilic esophagitis. Gastroenterology. 2018;**154**(2):319-332.e3. DOI: 10.1053/j. gastro.2017.06.067

[124] Sherrill JD, Gao P-S, Stucke EM, Blanchard C, Collins MH, Putnam PE, et al. Variants of thymic

stromal lymphopoietin and its receptor associate with eosinophilic esophagitis. The Journal of Allergy and Clinical Immunology. 2010;**126**(1):160-5.e3. DOI: 10.1016/j.jaci.2010.04.037

[125] Kelly KJ, Lazenby AJ, Rowe PC, Yardley JH, Perman JA, Sampson HA. Eosinophilic esophagitis attributed to gastroesophageal reflux: Improvement with an amino acid-based formula. Gastroenterology. 1995;**109**(5):1503-1512. DOI: 10.1016/0016-5085(95)90637-1

[126] Liacouras CA, Spergel JM, Ruchelli E, Verma R, Mascarenhas M, Semeao E, et al. Eosinophilic esophagitis: A 10-year experience in 381 children. Clinical Gastroenterology and Hepatology. 2005;**3**(12):1198-1206. DOI: 10.1016/s1542-3565(05)00885-2

[127] Arias Á, González-Cervera J, Tenias JM, Lucendo AJ. Efficacy of dietary interventions for inducing histologic remission in patients with eosinophilic esophagitis: A systematic review and meta-analysis. Gastroenterology. 2014;**146**(7):1639- 1648. Available from: https://www. sciencedirect.com/science/article/pii/ S0016508514002170

[128] Blanchard C, Wang N, Stringer KF, Mishra A, Fulkerson PC, Abonia JP, et al. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. The Journal of Clinical Investigation. 2006;**116**(2):536-547. DOI: 10.1172/JCI26679

[129] Spergel JM, Brown-Whitehorn TF, Beausoleil JL, Franciosi J, Shuker M, Verma R, et al. 14 years of eosinophilic esophagitis: Clinical features and prognosis. Journal of Pediatric Gastroenterology and Nutrition. 2009;**48**(1):30-36. DOI: 10.1097/ MPG.0b013e3181788282

*Autoimmune Diseases of the GI Tract Part I: Etiology and Pathophysiology DOI: http://dx.doi.org/10.5772/intechopen.106184*

[130] Rothenberg ME, Spergel JM, Sherrill JD, Annaiah K, Martin LJ, Cianferoni A, et al. Common variants at 5q22 associate with pediatric eosinophilic esophagitis. Nature Genetics. 2010;**42**(4):289-291. DOI: 10.1038/ng.547

[131] Simon D, Cianferoni A, Spergel JM, Aceves S, Holbreich M, Venter C, et al. Eosinophilic esophagitis is characterized by a non-IgE-mediated food hypersensitivity. Allergy. 2016;**71**(5):611- 620. Available from: https://onlinelibrary. wiley.com/doi/10.1111/all.12846

[132] Fogg MI, Ruchelli E, Spergel JM. Pollen and eosinophilic esophagitis. The Journal of Allergy and Clinical Immunology. 2003;**112**(4):796-797. DOI: 10.1016/s0091-6749(03)01715-9

[133] Spergel JM, Beausoleil JL, Mascarenhas M, Liacouras CA. The use of skin prick tests and patch tests to identify causative foods in eosinophilic esophagitis. The Journal of Allergy and Clinical Immunology. 2002;**109**(2):363- 368. DOI: 10.1067/mai.2002.121458

[134] Cotton CC, Eluri S, Wolf WA, Dellon ES. Six-food elimination diet and topical steroids are effective for eosinophilic esophagitis: A metaregression. Digestive Diseases and Sciences. 2017;**62**(9):2408-2420. DOI: 10.1007/s10620-017-4642-7

[135] Blanchard C, Mishra A, Saito-Akei H, Monk P, Anderson I, Rothenberg ME. Inhibition of human interleukin-13-induced respiratory and oesophageal inflammation by anti-human-interleukin-13 antibody (CAT-354). Clinical and Experimental Allergy. 2005;**35**(8):1096-1103. Available from: https://onlinelibrary.wiley.com/ doi/10.1111/j.1365-2222.2005.02299.x

[136] Muir AB, Lim DM, Benitez AJ, Modayur Chandramouleeswaran P,

Lee AJ, Ruchelli ED, et al. Esophageal epithelial and mesenchymal crosstalk leads to features of epithelial to mesenchymal transition in vitro. Experimental Cell Research. 2013;**319**(6):850-859. DOI: 10.1016/j. yexcr.2012.12.002

[137] Wenzel SE, Schwartz LB, Langmack EL, Halliday JL, Trudeau JB, Gibbs RL, et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. American Journal of Respiratory and Critical Care Medicine. 1999;**160**(3):1001-1008. DOI: 10.1164/ ajrccm.160.3.9812110

[138] Lyles J, Rothenberg M. Role of genetics, environment, and their interactions in the pathogenesis of eosinophilic esophagitis. Current Opinion in Immunology. 2019;**60**:46-53. DOI: 10.1016/j.coi.2019.04.004

[139] Dellon ES. Eosinophilic esophagitis. Gastroenterology Clinics of North America. 2013;**42**(1):133-153. DOI: 10.1016/j.gtc.2012.11.008

[140] Aceves SS, Newbury RO, Dohil R, Schwimmer J, Bastian JF. Distinguishing eosinophilic esophagitis in pediatric patients: Clinical, endoscopic, and histologic features of an emerging disorder. Journal of Clinical Gastroenterology. 2007;**41**(3):252-256. DOI: 10.1097/01.mcg.0000212639. 52359.f1

[141] Veerappan GR, Perry JL, Duncan TJ, Baker TP, Maydonovitch C, Lake JM, et al. Prevalence of eosinophilic esophagitis in an adult population undergoing upper endoscopy: A prospective study. Clinical Gastroenterology and Hepatology. 2009;**7**(4):420-426.e2. DOI: 10.1016/j. cgh.2008.10.009

[142] Sealock RJ, Kramer JR, Verstovsek G, Richardson P, Rugge M, Parente P, et al. The prevalence of oesophageal eosinophilia and eosinophilic oesophagitis: A prospective study in unselected patients presenting to endoscopy. Alimentary Pharmacology & Therapeutics. 2013;**37**(8):825-832. DOI: 10.1111/apt.12268

[143] Joo MK, Park J-J, Kim S-H, Kim KH, Jung W, Yun J-W, et al. Prevalence and endoscopic features of eosinophilic esophagitis in patients with esophageal or upper gastrointestinal symptoms. Journal of Digestive Diseases. 2012;**13**(6):296-303. Available from: https://onlinelibrary.wiley.com/ doi/10.1111/j.1751-2980.2012.00589.x

[144] Assiri AM, Saeed A. Incidence and diagnostic features of eosinophilic esophagitis in a group of children with dysphagia and gastroesophageal reflux disease. Saudi Medical Journal. 2014;**35**(3):292-297. Available from: https://www.ncbi.nlm.nih.gov/ pubmed/24623210

[145] Gonsalves N, Policarpio-Nicolas M, Zhang Q, Rao MS, Hirano I. Histopathologic variability and endoscopic correlates in adults with eosinophilic esophagitis. Gastrointestinal Endoscopy. 2006;**64**(3):313-319. DOI: 10.1016/j.gie.2006.04.037

[146] Dellon ES, Gibbs WB, Fritchie KJ, Rubinas TC, Wilson LA, Woosley JT, et al. Clinical, endoscopic, and histologic findings distinguish eosinophilic esophagitis from gastroesophageal reflux disease. Clinical Gastroenterology and Hepatology. 2009;**7**(12):1305-1313. quiz 1261. DOI: 10.1016/j.cgh.2009.08.030

[147] Sperry SLW, Crockett SD, Miller CB, Shaheen NJ, Dellon ES. Esophageal foreign-body impactions: Epidemiology, time trends, and the impact of the

increasing prevalence of eosinophilic esophagitis. Gastrointestinal Endoscopy. 2011;**74**(5):985-991. DOI: 10.1016/j. gie.2011.06.029

[148] Dellon ES, Kim HP, Sperry SLW, Rybnicek DA, Woosley JT, Shaheen NJ. A phenotypic analysis shows that eosinophilic esophagitis is a progressive fibrostenotic disease. Gastrointestinal Endoscopy. 2014;**79**(4):577-85.e4. DOI: 10.1016/j.gie.2013.10.027

[149] Dellon ES, Liacouras CA. Advances in clinical management of eosinophilic esophagitis. Gastroenterology. 2014;**147**(6):1238-1254. DOI: 10.1053/j. gastro.2014.07.055

[150] Hiremath GS, Hameed F, Pacheco A, Olive A, Davis CM, Shulman RJ. Esophageal food impaction and eosinophilic esophagitis: A retrospective study, systematic review, and meta-analysis. Digestive Diseases and Sciences. 2015;**60**(11):3181-3193. DOI: 10.1007/s10620-015-3723-8

[151] Dellon ES, Gonsalves N, Hirano I, Furuta GT, Liacouras CA, Katzka DA, et al. ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). The American Journal of Gastroenterology. 2013;**108**(5):679-692. quiz 693. DOI: 10.1038/ajg.2013.71

[152] Strober W, Fuss I, Mannon P. The fundamental basis of inflammatory bowel disease. The Journal of Clinical Investigation. 2007;**117**(3):514-521. DOI: 10.1172/JCI30587

[153] Hou JK, El-Serag H, Thirumurthi S. Distribution and manifestations of inflammatory bowel disease in Asians, Hispanics, and African Americans: A systematic review. The American Journal of Gastroenterology.

*Autoimmune Diseases of the GI Tract Part I: Etiology and Pathophysiology DOI: http://dx.doi.org/10.5772/intechopen.106184*

2009;**104**(8):2100-2109. DOI: 10.1038/ ajg.2009.190

[154] Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;**142**(1):46- 54.e42. quiz e30. DOI: 10.1053/j. gastro.2011.10.001

[155] Cosnes J, Gower-Rousseau C, Seksik P, Cortot A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology. 2011;**140**(6):1785-1794. DOI: 10.1053/j. gastro.2011.01.055

[156] Sairenji T, Collins KL, Evans DV. An update on inflammatory bowel disease. Primary Care. 2017;**44**(4):673-692. DOI: 10.1016/j.pop.2017.07.010

[157] Hampe J, Franke A, Rosenstiel P, Till A, Teuber M, Huse K, et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nature Genetics. 2007;**39**(2):207-211. DOI: 10.1038/ng1954

[158] Rioux JD, Xavier RJ, Taylor KD, Silverberg MS, Goyette P, Huett A, et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nature Genetics. 2007;**39**(5):596-604. Available from: https://www.nature.com/articles/ng2032

[159] McCarroll SA, Huett A, Kuballa P, Chilewski SD, Landry A, Goyette P, et al. Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease. Nature Genetics. 2008;**40**(9):1107-1112. Available from: https://www.nature.com/ articles/ng.215

[160] Liu T-C, Stappenbeck TS. Genetics and pathogenesis of inflammatory bowel disease. Annual Review of Pathology. 2016;**11**:127-148. DOI: 10.1146/ annurev-pathol-012615-044152

[161] Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ, et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science. 2006;**314**(5804):1461- 1463. DOI: 10.1126/science.1135245

[162] Liu Z-J, Yadav P-K, Su J-L, Wang J-S, Fei K. Potential role of Th17 cells in the pathogenesis of inflammatory bowel disease. World Journal of Gastroenterology. 2009;**15**(46):5784- 5788. Available from: http://www.wjgnet. com/1007-9327/full/v15/i46/5784.htm

[163] Lees CW, Satsangi J. Genetics of inflammatory bowel disease: Implications for disease pathogenesis and natural history. Expert Review of Gastroenterology & Hepatology. 2009;**3**(5):513-534. DOI: 10.1586/ egh.09.45

[164] Polgar N, Csongei V, Szabo M, Zambo V, Melegh BI, Sumegi K, et al. Investigation of JAK2, STAT3 and CCR6 polymorphisms and their genegene interactions in inflammatory bowel disease. International Journal of Immunogenetics. 2012;**39**(3):247-252. Available from: https://onlinelibrary.wiley.com/ doi/10.1111/j.1744-313X.2012.01084.x

[165] Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011;**474**(7351):307-317. DOI: 10.1038/ nature10209

[166] Ahmad T, Satsangi J, McGovern D, Bunce M, Jewell DP. Review article: The genetics of inflammatory bowel disease. Alimentary Pharmacology

& Therapeutics. 2001;**15**(6):731-748. Available from: http://doi.wiley. com/10.1046/j.1365-2036.2001.00981.x

[167] Ponder A, Long MD. A clinical review of recent findings in the epidemiology of inflammatory bowel disease. Clinical Epidemiology. 2013;**5**:237-247. DOI: 10.2147/CLEP. S33961

[168] Manichanh C, Borruel N, Casellas F, Guarner F. The gut microbiota in IBD. Nature Reviews. Gastroenterology & Hepatology. 2012;**9**(10):599-608. DOI: 10.1038/nrgastro.2012.152

[169] Ni J, Wu GD, Albenberg L, Tomov VT. Gut microbiota and IBD: Causation or correlation? Nature Reviews. Gastroenterology & Hepatology. 2017;**14**(10):573-584. Available from: https://www.nature.com/ articles/nrgastro.2017.88

[170] Ananthakrishnan AN, Bernstein CN, Iliopoulos D, Macpherson A, Neurath MF, Ali RAR, et al. Environmental triggers in IBD: A review of progress and evidence. Nature Reviews. Gastroenterology & Hepatology. 2018;**15**(1):39-49. DOI: 10.1038/nrgastro.2017.136

[171] van Eeden SF, Tan WC, Suwa T, Mukae H, Terashima T, Fujii T, et al. Cytokines involved in the systemic inflammatory response induced by exposure to particulate matter air pollutants (PM10). American Journal of Respiratory and Critical Care Medicine. 2001;**164**(5):826-830. DOI: 10.1164/ ajrccm.164.5.2010160

[172] Thia KT, Loftus EV Jr, Sandborn WJ, Yang S-K. An update on the epidemiology of inflammatory bowel disease in Asia. The American Journal of Gastroenterology.

2008;**103**(12):3167-3182. DOI: 10.1111/ j.1572-0241.2008. 02158.x

[173] Kaplan GG, Hubbard J, Korzenik J, Sands BE, Panaccione R, Ghosh S, et al. The inflammatory bowel diseases and ambient air pollution: A novel association. The American Journal of Gastroenterology. 2010;**105**(11):2412- 2419. Available from: https://journals. lww.com/00000434-201011000-00017

[174] Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology. 2004;**126**(6):1504- 1517. DOI: 10.1053/j.gastro.2004.01.063

[175] Fletcher J, Cooper SC, Ghosh S, Hewison M. The role of vitamin D in inflammatory bowel disease: Mechanism to management. Nutrients. 2019;**11**(5):10.3390/nu11051019

[176] Sgambato D, Miranda A, Ranaldo R, Federico A, Romano M. The role of stress in inflammatory bowel diseases. Current Pharmaceutical Design. 2017;**23**(27):3997-4002. DOI: 10.2174/ 1381612823666170228123357

[177] Travis SPL, Stange EF, Lémann M, Oresland T, Chowers Y, Forbes A, et al. European evidence based consensus on the diagnosis and management of Crohn's disease: Current management. Gut. 2006;**55**(Suppl. 1):i16-i35. DOI: 10.1136/ gut.2005.081950b

[178] Tripathi K, Feuerstein JD. New developments in ulcerative colitis: Latest evidence on management, treatment, and maintenance. Drugs Context. 2019;**8**:212572. Available from: https://www.drugsincontext.com/ new-developments-in-ulcerative-colitis: latest-evidence-on-management, treatment,-and-maintenance

*Autoimmune Diseases of the GI Tract Part I: Etiology and Pathophysiology DOI: http://dx.doi.org/10.5772/intechopen.106184*

[179] Cheifetz AS. Management of active Crohn disease. Journal of the American Medical Association. 2013;**309**(20):2150- 2158. DOI: 10.1001/jama.2013.4466

[180] Torres J, Mehandru S, Colombel J-F, Peyrin-Biroulet L. Crohn's disease. Lancet. 2017;**389**(10080):1741-1755. DOI: 10.1016/S0140-6736(16)31711-1

[181] Kappelman MD, Rifas-Shiman SL, Kleinman K, Ollendorf D, Bousvaros A, Grand RJ, et al. The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clinical Gastroenterology and Hepatology. 2007;**5**(12):1424-1429. DOI: 10.1016/j.cgh.2007.07.012

[182] Ng SC, Bernstein CN, Vatn MH, Lakatos PL, Loftus EV Jr, Tysk C, et al. Geographical variability and environmental risk factors in inflammatory bowel disease. Gut. 2013;**62**(4):630-649. DOI: 10.1136/ gutjnl-2012-303661

[183] Huang H, Fang M, Jostins L, Umićević Mirkov M, Boucher G, Anderson CA, et al. Fine-mapping inflammatory bowel disease loci to single-variant resolution. Nature. 2017;**547**(7662):173-178. Available from: https://www.nature.com/articles/ nature22969

[184] Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, et al. Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;**491**(7422):119-124. Available from: https://www.nature.com/articles/ nature11582

[185] Ellinghaus D, Jostins L, Spain SL, Cortes A, Bethune J, Han B, et al. Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci. Nature Genetics. 2016;**48**(5):510-518. Available from: https://www.nature.com/articles/ng.3528

[186] Hugot JP, Chamaillard M, Zouali H, Lesage S, Cézard JP, Belaiche J, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001;**411**(6837):599-603. DOI: 10.1038/35079107

[187] Roda G, Chien Ng S, Kotze PG, Argollo M, Panaccione R, Spinelli A, et al. Crohn's disease. Nature Reviews Disease Primers. 2020;**6**(1):22. DOI: 10.1038/s41572-020-0156-2

[188] Zhu L, Shi T, Zhong C, Wang Y, Chang M, Liu X. IL-10 and IL-10 receptor mutations in very early onset inflammatory bowel disease. Gastroenterology Research and Practice. 2017;**10**(2):65-69. DOI: 10.14740/gr740w

[189] Feuerstein JD, Cheifetz AS. Crohn disease: Epidemiology, diagnosis, and management. Mayo Clinic Proceedings. 2017;**92**(7):1088-1103. DOI: 10.1016/j. mayocp.2017.04.010

[190] Danese S, Fiorino G, Mary J-Y, Lakatos PL, D'Haens G, Moja L, et al. Development of red flags index for early referral of adults with symptoms and signs suggestive of Crohn's disease: An IOIBD initiative. Journal of Crohn's & Colitis. 2015;**9**(8):601-606. DOI: 10.1093/ ecco-jcc/jjv067

[191] Plevy S, Silverberg MS, Lockton S, Stockfisch T, Croner L, Stachelski J, et al. Combined serological, genetic, and inflammatory markers differentiate non-IBD, Crohn's disease, and ulcerative colitis patients. Inflammatory Bowel Diseases. 2013;**19**(6):1139-1148. DOI: 10.1097/MIB.0b013e318280b19e

[192] Mitsuyama K, Niwa M, Takedatsu H, Yamasaki H, Kuwaki K, Yoshioka S, et al. Antibody markers in the diagnosis of inflammatory bowel disease. World Journal of Gastroenterology. 2016;**22**(3):1304-1310. DOI: 10.3748/wjg.v22.i3.1304

[193] Gu P, Kapur A, Li D, Haritunians T, Vasiliauskas E, Shih DQ, et al. Serological, genetic and clinical associations with increased health-care resource utilization in inflammatory bowel disease. Journal of Digestive Diseases. 2018;**19**(1):15-23. Available from: https://onlinelibrary.wiley.com/ doi/10.1111/1751-2980.12566

[194] Silverberg MS, Satsangi J, Ahmad T, Arnott IDR, Bernstein CN, Brant SR, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a working party of the 2005 Montreal world congress of gastroenterology. Canadian Journal of Gastroenterology. 2005;**19**(Suppl. A):5A-36A. DOI: 10.1155/ 2005/269076

[195] Colitis-Pathophysiology U. Inflammatory bowel disease part I: Ulcerative colitis-pathophysiology and conventional and alternative treatment options. Alternative Medicine Review. 2003;**8**(3):247-283. Available from: http://www.anaturalhealingcenter.com/ documents/Thorne/articles/bowel\_ disease8-3.pdf

[196] Das KM, Biancone L. Is IBD an autoimmune disorder? Inflammatory Bowel Diseases. 2008;**14**(Suppl. 2):S97- S101. DOI: 10.1002/ibd.20723

[197] Wei S-C, Sollano J, Hui YT, Yu W, Santos Estrella PV, Llamado LJQ, et al. Epidemiology, burden of disease, and unmet needs in the treatment of ulcerative colitis in Asia. Expert Review of Gastroenterology & Hepatology. 2021;**15**(3):275-289. DOI: 10.1080/17474124.2021.1840976

[198] Gajendran M, Loganathan P, Jimenez G, Catinella AP, Ng N, Umapathy C, et al. A comprehensive review and update on ulcerative colitis. Disease-a-Month. 2019;**65**(12):100851. DOI: 10.1016/j.disamonth.2019.02.004

[199] Persson PG, Ahlbom A, Hellers G. Diet and inflammatory bowel disease: A case-control study. Epidemiology. 1992;**3**(1):47-52. DOI: 10.1097/00001648- 199201000-00009

[200] Tragnone A, Valpiani D, Miglio F, Elmi G, Bazzocchi G, Pipitone E, et al. Dietary habits as risk factors for inflammatory bowel disease. European Journal of Gastroenterology & Hepatology. 1995;**7**(1):47-51. Available from: https://www.ncbi.nlm.nih.gov/ pubmed/7866810

[201] Morris DL, Montgomery SM, Galloway ML, Pounder RE, Wakefield AJ. Inflammatory bowel disease and laterality: Is left handedness a risk? Gut. 2001;**49**(2):199-202. DOI: 10.1136/gut.49.2.199

[202] Frolkis AD, Vallerand IA, Shaheen A-A, Lowerison MW, Swain MG, Barnabe C, et al. Depression increases the risk of inflammatory bowel disease, which may be mitigated by the use of antidepressants in the treatment of depression. Gut. 2019;**68**(9):1606-1612. Available from: https://gut.bmj.com/ content/68/9/1606.abstract

[203] Nahon S, Lahmek P, Durance C, Olympie A, Lesgourgues B, Colombel J-F, et al. Risk factors of anxiety and depression in inflammatory bowel disease. Inflammatory Bowel Diseases. 2012;**18**(11):2086-2091. DOI: 10.1002/ ibd.22888

[204] Edwards JR, Caplan RD, Van Harrison R. Person-environment fit theory. Theories of Organizational

*Autoimmune Diseases of the GI Tract Part I: Etiology and Pathophysiology DOI: http://dx.doi.org/10.5772/intechopen.106184*

Stress. 1998;**28**(1):67-94. Available from: https://public.kenan-flagler.unc.edu/ faculty/edwardsj/edwardsetal1998.pdf

[205] Selye H. A syndrome produced by diverse nocuous agents. Nature. 1936;**138**(3479):32-32. Available from: https://www.nature.com/ articles/138032a0

[206] Mark LF, Matheny J, Kolt GS. Eustress, distress, and interpretation in occupational stress. Journal of Managerial Psychology. 2003;**18**(7):726- 744. DOI: 10.1108/02683940310502412

[207] Bhargava D, Trivedi H, Others. A study of causes of stress and stress management among youth. IRA-International Journal of Management & Social Sciences. 2018;**11**(03):108-117. Available from: https://www.academia. edu/download/71278322/1ee3ebf6bf3618 4a12247dc2d7b17dd80371.pdf

[208] Dean J, Keshavan M. The neurobiology of depression: An integrated view. Asian Journal of Psychiatry. 2017;**27**:101-111. DOI: 10.1016/j.ajp.2017.01.025

[209] Wheaton B. The nature of stressors. In: Horwitz AV, editor. A Handbook for the Study of Mental Health: Social Contexts, Theories, and Systems. Vol. xvii. New York, NY, US: Cambridge University Press; 1999. pp. 176-197. Available from: https://psycnet.apa.org/ fulltext/1999-02431-009.pdf

[210] Harbuz MS, Richards LJ, Chover-Gonzalez AJ, Marti-Sistac O, Jessop DS. Stress in autoimmune disease models. Annals of the New York Academy of Sciences. 2006;**1069**:51-61. DOI: 10.1196/annals.1351.005

[211] Glaser R, Kiecolt-Glaser JK. Stress-induced immune dysfunction: Implications for health. Nature Reviews. Immunology. 2005;**5**(3):243-251. DOI: 10.1038/nri1571

[212] Song H, Fang F, Tomasson G, Arnberg FK, Mataix-Cols D, Fernández de la Cruz L, et al. Association of stress-related disorders with subsequent autoimmune disease. Journal of the American Medical Association. 2018;**319**(23):2388-2400. DOI: 10.1001/jama.2018.7028

[213] Selye H. The stress of life. repositorio.cenpat-conicet.gob.ar; 1956. Available from: http://www.repositorio. cenpat-conicet.gob.ar/bitstream/ handle/123456789/415/theStressOfLife. pdf?sequence=1

[214] Frieri M. Neuroimmunology and inflammation: Implications for therapy of allergic and autoimmune diseases. Annals of Allergy, Asthma & Immunology. 2003;**90**(6 Suppl. 3):34-40. DOI: 10.1016/s1081-1206(10)61658-4

[215] Stojanovich L, Marisavljevich D. Stress as a trigger of autoimmune disease. Autoimmunity Reviews. 2008;**7**(3):209-213. DOI: 10.1016/j. autrev.2007.11.007

[216] Chida Y, Sudo N, Kubo C. Social isolation stress exacerbates autoimmune disease in MRL/lpr mice. Journal of Neuroimmunology. 2005;**158** (1-2):138-144. DOI: 10.1016/j. jneuroim.2004.09.002

[217] Stam R. PTSD and stress sensitisation: A tale of brain and body part 1: Human studies. Neuroscience and Biobehavioral Reviews. 2007;**31**(4):530- 557. DOI: 10.1016/j.neubiorev.2006.11.010

[218] Kalantari M, Hollywood A, Lim R, Hashemi M. Mapping the experiences of people with achalasia from initial symptoms to long-term management. Health Expectations. 2021;**24**(1):131-139. Available from: https://onlinelibrary. wiley.com/doi/10.1111/hex.13160

[219] Loosen SH, Kandler J, Luedde T, Kostev K, Roderburg C. Achalasia is associated with a higher incidence of depression in outpatients in Germany. PLoS ONE. 2021;**16**(4):e0250503. DOI: 10.1371/journal.pone.0250503

[220] Elseweidy MM. Brief review on the causes, diagnosis and therapeutic treatment of gastritis disease. Alternative and Integrative Medicine. 2017;**06**(01):1-6. Available from: https:// www.esciencecentral.org/journals/briefreview-on-the-causes-diagnosis-andtherapeutic-treatment-of-gastritisdise ase-2327-5162-1000231.php?aid=86738

[221] Miceli E, Brondino N, Lenti MV, Di Stefano M, Staiani M, Zugnoni F, et al. Impaired quality of life in patients with autoimmune atrophic gastritis. Digestive Diseases and Sciences. 2021;**66**(10):3322- 3329. DOI: 10.1007/s10620-020-06656-x

[222] Tenca A, Massironi S, Pugliese D, Consonni D, Mauro A, Cavalcoli F, et al. Gastro-esophageal reflux and antisecretory drugs use among patients with chronic autoimmune atrophic gastritis: A study with pH-impedance monitoring. Neurogastroenterology and Motility. 2016;**28**(2):274-280. DOI: 10.1111/nmo.12723

[223] Takeoka A, Tayama J, Kobayashi M, Sagara I, Ogawa S, Saigo T, et al. Psychological effects of Helicobacter pylori-associated atrophic gastritis in patients under 50 years: A cross-sectional study. Helicobacter. 2017;**22**(6):e12445. Available from: https://onlinelibrary.wiley. com/doi/10.1111/hel.12445

[224] Zhao X, Wu M, Zhang D, Sun Y, Yang Y, Xie H, et al. The relationship of interpersonal sensitivity and depression among patients with chronic atrophic

gastritis: The mediating role of coping styles. Journal of Clinical Nursing. 2018;**27**(5-6):e984-e991. DOI: 10.1111/ jocn.14114

[225] Smith LB, Lynch KF, Kurppa K, Koletzko S, Krischer J, Liu E, et al. Psychological manifestations of celiac disease autoimmunity in young children. Pediatrics. 2017;**139**(3):10.1542/ peds.2016-2848

[226] Zingone F, Swift GL, Card TR, Sanders DS, Ludvigsson JF, Bai JC. Psychological morbidity of celiac disease: A review of the literature. United European Gastroenterology Journal. 2015;**3**(2):136-145. DOI: 10.1177/2050640614560786

[227] Mårild K, Frostell AS, Ludvigsson JF. Psychological stress and coeliac disease in childhood: A cohort study. BMC Gastroenterology. 2010;**10**(106):1-6. DOI: 10.1186/ 1471-230X-10-106

[228] Addolorato G, Capristo E, Ghittoni G, Valeri C, Mascianà R, Ancona C, et al. Anxiety but not depression decreases in coeliac patients after one-year gluten-free diet: A longitudinal study. Scandinavian Journal of Gastroenterology. 2001;**36**(5):502-506. DOI: 10.1080/00365520119754

[229] Lebwohl B, Haggård L, Emilsson L, Söderling J, Roelstraete B, Butwicka A, et al. Psychiatric disorders in patients with a diagnosis of celiac disease during childhood from 1973 to 2016. Clinical Gastroenterology and Hepatology. 2021;**19**(10):2093-2101.e13. DOI: 10.1016/j.cgh.2020.08.018

[230] Wahab RJ, Beth SA, Derks IPM, Jansen PW, Moll HA, Kiefte-de Jong JC. Celiac disease autoimmunity and emotional and behavioral problems in childhood. Pediatrics.

*Autoimmune Diseases of the GI Tract Part I: Etiology and Pathophysiology DOI: http://dx.doi.org/10.5772/intechopen.106184*

2019;**144**(4):e20183933. DOI: 10.1542/ peds.2018-3933

[231] Prugh DG. A preliminary report on the role of emotional factors in idiopathic celiac disease. Psychosomatic Medicine. 1951;**13**(4):220-241. DOI: 10.1097/00006842-195107000- 00002

[232] Addolorato G, Stefanini GF, Capristo E, Caputo F, Gasbarrini A, Gasbarrini G. Anxiety and depression in adult untreated celiac subjects and in patients affected by inflammatory bowel disease: A personality "trait" or a reactive illness? Hepato-Gastroenterology. 1996;**43**(12):1513-1517. Available from: https://www.ncbi.nlm.nih.gov/ pubmed/8975957

[233] Carta MG, Hardoy MC, Boi MF, Mariotti S, Carpiniello B, Usai P. Association between panic disorder, major depressive disorder and celiac disease: A possible role of thyroid autoimmunity. Journal of Psychosomatic Research. 2002;**53**(3):789-793. DOI: 10.1016/s0022-3999(02)00328-8

[234] Fera T, Cascio B, Angelini G, Martini S, Guidetti CS. Affective disorders and quality of life in adult coeliac disease patients on a gluten-free diet. European Journal of Gastroenterology & Hepatology. 2003;**15**(12):1287-1292. DOI: 10.1097/00042737-200312000- 00006

[235] Cicarelli G, Della Rocca G, Amboni M, Ciacci C, Mazzacca G, Filla A, et al. Clinical and neurological abnormalities in adult celiac disease. Neurological Sciences. 2003;**24**(5):311- 317. DOI: 10.1007/s10072-003-0181-4

[236] Pynnönen PA, Isometsä ET, Aronen ET, Verkasalo MA, Savilahti E, Aalberg VA. Mental disorders in adolescents with celiac disease.

Psychosomatics. 2004;**45**(4):325-335. DOI: 10.1176/appi.psy.45.4.325

[237] Siniscalchi M, Iovino P, Tortora R, Forestiero S, Somma A, Capuano L, et al. Fatigue in adult coeliac disease. Alimentary Pharmacology & Therapeutics. 2005;**22**(5):489-494. DOI: 10.1111/j.1365-2036.2005.02619.x

[238] Ludvigsson JF, Reutfors J, Ösby U, Ekbom A, Montgomery SM. Coeliac disease and risk of mood disorders—A general population-based cohort study. Journal of Affective Disorders. 2007;**99**(1-3):117-126. Available from: https://www.sciencedirect.com/science/ article/pii/S0165032706003636?casa\_ token=M7hqiBpFN-oAAAAA:vXR\_ Qk5XdsAIQyOSpDnwsxNjDw8qYSKJ\_ w03LMBFadsbH7kdvTWpRPJ4fO2w8A-13dPKBKiCmrI

[239] Mazzone L, Reale L, Spina M, Guarnera M, Lionetti E, Martorana S, et al. Compliant gluten-free children with celiac disease: An evaluation of psychological distress. BMC Pediatrics. 2011;**11**:46. DOI: 10.1186/1471-2431-11-46

[240] Butwicka A, Lichtenstein P, Frisén L, Almqvist C, Larsson H, Ludvigsson JF. Celiac disease is associated with childhood psychiatric disorders: A population-based study. The Journal of Pediatrics. 2017;**184**:87-93.e1. DOI: 10.1016/j.jpeds.2017.01.043

[241] Carta MG, Conti A, Lecca F, Sancassiani F, Cossu G, Carruxi R, et al. The burden of depressive and bipolar disorders in celiac disease. Clinical Practice and Epidemiology in Mental Health. 2015;**11**(1):180-185. Available from: https://clinical-practice-andepidemiology-in-mental-health.com/ VOLUME/11/PAGE/180/

[242] Addolorato G, Mirijello A, D'Angelo C, Leggio L, Ferrulli A, Vonghia L, et al. Social phobia in coeliac disease. Scandinavian Journal of Gastroenterology. 2008;**43**(4):410-415. DOI: 10.1080/00365520701768802

[243] Clappison E, Hadjivassiliou M, Zis P. Psychiatric manifestations of coeliac disease, a systematic review and metaanalysis. Nutrients. 2020;**12**(1):142-158. DOI: 10.3390/nu12010142

[244] Taft TH, Guadagnoli L, Edlynn E. Anxiety and depression in eosinophilic esophagitis: A scoping review and recommendations for future research. Journal of Asthma and Allergy. 2019;**12**:389-399. DOI: 10.2147/JAA. S193045

[245] de Rooij WE, Bennebroek Evertsz' F, Lei A, Bredenoord AJ. Mental distress among adult patients with eosinophilic esophagitis. Neurogastroenterology and Motility. 2021;**33**(7):e14069. DOI: 10.1111/nmo.14069

[246] Erickson MA, Morofuji Y, Owen JB, Banks WA. Rapid transport of CCL11 across the blood-brain barrier: Regional variation and importance of blood cells. The Journal of Pharmacology and Experimental Therapeutics. 2014;**349**(3):497-507. DOI: 10.1124/ jpet.114.213074

[247] Krathwohl MD, Kaiser JL. Chemokines promote quiescence and survival of human neural progenitor cells. Stem Cells. 2004;**22**(1):109-118. DOI: 10.1634/stemcells.22-1-109

[248] Parajuli B, Horiuchi H, Mizuno T, Takeuchi H, Suzumura A. CCL11 enhances excitotoxic neuronal death by producing reactive oxygen species in microglia. Glia. 2015;**63**(12):2274-2284. DOI: 10.1002/ glia.22892

[249] Simon NM, McNamara K, Chow CW, Maser RS, Papakostas GI, Pollack MH, et al. A detailed examination of cytokine abnormalities in major depressive disorder. European Neuropsychopharmacology. 2008;**18**(3):230-233. DOI: 10.1016/j. euroneuro.2007.06.004

[250] Crohn BB, Burrill B, Ginzburg, Leon, Oppenheimer, Gordon D. Regional Ileitis: A pathologic and clinical entity. JAMA. 1984;**251**(1):73-79. Available from: https://jamanetwork.com/ journals/jama/article-abstract/390889

[251] Parfitt HL. Psychiatric aspects of regional enteritis. Canadian Medical Association Journal. 1967;**97**(13):807- 811. Available from: https://www.ncbi. nlm.nih.gov/pubmed/6050900

[252] Ford CV, Glober GA, Castelnuovo-Tedesco P. A psychiatric study of patients with regional enteritis. Journal of the American Medical Association. 1969;**208**(2):311-315. Available from: https://www.ncbi.nlm. nih.gov/pubmed/4388299

[253] Cohn EM, Lederman II, Shore E. Regional enteritis and its relation to emotional disorders. The American Journal of Gastroenterology. 1970;**54**(4):378-387. Available from: https://www.ncbi.nlm.nih.gov/ pubmed/5478850

[254] Schwartz RA, Schwartz IK. Psychiatric disorders associated with Crohn's disease. International Journal of Psychiatry in Medicine. 1982;**12**(1):67-73. DOI: 10.2190/fl8y-1wu6-1n5l-1fqv

[255] Helzer JE, Chammas S, Norland CC, Stillings WA, Alpers DH. A study of the association between Crohn's disease and psychiatric illness. Gastroenterology. 1984;**86**(2):324-330. Available from:

*Autoimmune Diseases of the GI Tract Part I: Etiology and Pathophysiology DOI: http://dx.doi.org/10.5772/intechopen.106184*

https://www.ncbi.nlm.nih.gov/ pubmed/6690360

[256] Engel GL. Psychological factors in ulcerative colitis in man and gibbon. Gastroenterology. 1969;**57**(3):362-365. Available from: https://www.ncbi.nlm. nih.gov/pubmed/5808494

[257] Mawdsley JE, Macey MG, Feakins RM, Langmead L, Rampton DS. The effect of acute psychologic stress on systemic and rectal mucosal measures of inflammation in ulcerative colitis. Gastroenterology. 2006;**131**(2):410-419. DOI: 10.1053/j.gastro.2006.05.017

[258] Angelopoulos NV, Mantas C, Dalekos GN, Vasalos K, Tsianos EV. Psychiatric factors in patients with ulcerative colitis according to disease activity. European Psychiatry. 1996;**10**(2):87-99. Available from: https://www.researchgate.net/ profile/Nikiforos-Angelopoulos/ publication/289310216\_Psychiatric\_ factors\_in\_patients\_with\_ulcerative\_ colitis\_according\_to\_disease\_activity/ links/58a746fe4585150402f29fda/ Psychiatric-factors-in-patients-withulcerative-colitis-according-to-diseaseactivity.pdf

[259] Marrie RA, Walld R, Bolton JM, Sareen J, Walker JR, Patten SB, et al. Physical comorbidities increase the risk of psychiatric comorbidity in immune-mediated inflammatory disease. General Hospital Psychiatry. 2018;**51**:71-78. DOI: 10.1016/j. genhosppsych.2018.01.003

[260] Araki M, Shinzaki S, Yamada T, Arimitsu S, Komori M, Shibukawa N, et al. Psychologic stress and disease activity in patients with inflammatory bowel disease: A multicenter cross-sectional study. PLoS ONE.

2020;**15**(5):e0233365. DOI: 10.1371/ journal.pone.0233365

[261] Lix LM, Graff LA, Walker JR, Clara I, Rawsthorne P, Rogala L, et al. Longitudinal study of quality of life and psychological functioning for active, fluctuating, and inactive disease patterns in inflammatory bowel disease. Inflammatory Bowel Diseases. 2008;**14**(11):1575-1584. DOI: 10.1002/ibd.20511

[262] Bernstein CN. Psychological stress and depression: Risk factors for IBD? Digestive Diseases. 2016;**34**(1-2):58-63. DOI: 10.1159/000442929

[263] Graff LA, Walker JR, Bernstein CN. Depression and anxiety in inflammatory bowel disease: A review of comorbidity and management. Inflammatory Bowel Diseases. 2009;**15**(7):1105-1118. DOI: 10.1002/ibd.20873

[264] Walker JR, Ediger JP, Graff LA, Greenfeld JM, Clara I, Lix L, et al. The Manitoba IBD cohort study: A population-based study of the prevalence of lifetime and 12-month anxiety and mood disorders. The American Journal of Gastroenterology. 2008;**103**(8):1989-1997. DOI: 10.1111/j.1572-0241.2008.01980.x

[265] Guthrie E, Jackson J, Shaffer J, Thompson D, Tomenson B, Creed F. Psychological disorder and severity of inflammatory bowel disease predict health-related quality of life in ulcerative colitis and Crohn's disease. The American Journal of Gastroenterology. 2002;**97**(8):1994-1999. DOI: 10.1111/j.1572-0241.2002.05842.x

[266] Ursell LK, Metcalf JL, Parfrey LW, Knight R. Defining the human microbiome. Nutrition Reviews. 2012;**70**(Suppl. 1):S38-S44. DOI: 10.1111/j.1753-4887.2012.00493.x [267] Chen X, D'Souza R, Hong S-T. The role of gut microbiota in the gut-brain axis: Current challenges and perspectives. Protein & Cell. 2013;**4**(6):403-414. DOI: 10.1007/ s13238-013-3017-x

[268] Favier CF, de Vos WM, Akkermans ADL. Development of bacterial and bifidobacterial communities in feces of newborn babies. Anaerobe. 2003;**9**(5):219-229. DOI: 10.1016/j.anaerobe.2003.07.001

[269] Koenig JE, Spor A, Scalfone N, Fricker AD, Stombaugh J, Knight R, et al. Succession of microbial consortia in the developing infant gut microbiome. Proceedings of the National Academy of Sciences of the United States of America. 2011;**108**(Suppl. 1):4578-4585. DOI: 10.1073/pnas.1000081107

[270] Milani C, Duranti S, Bottacini F, Casey E, Turroni F, Mahony J, et al. The first microbial colonizers of the human gut: Composition, activities, and health implications of the infant gut microbiota. Microbiology and Molecular Biology Reviews. 2017;**81**(4):e00036-17. DOI: 10.1128/MMBR.00036-17

[271] Thursby E, Juge N. Introduction to the human gut microbiota. Biochemical Journal. 2017;**474**(11):1823-1836. DOI: 10.1042/BCJ20160510

[272] Fitzgibbon G, Mills KHG. The microbiota and immune-mediated diseases: Opportunities for therapeutic intervention. European Journal of Immunology. 2020;**50**(3):326-337. Available from: https://onlinelibrary. wiley.com/doi/10.1002/eji.201948322

[273] West CE, Renz H, Jenmalm MC, Kozyrskyj AL, Allen KJ, Vuillermin P, et al. The gut microbiota and inflammatory noncommunicable diseases: Associations and potentials for gut microbiota

therapies. The Journal of Allergy and Clinical Immunology. 2015;**135**(1):3-13; quiz 14. DOI: 10.1016/j.jaci.2014.11.012

[274] Mehta S, Huey SL, McDonald D, Knight R, Finkelstein JL. Nutritional interventions and the gut microbiome in children. Annual Review of Nutrition. 2021;**41**:479-510. DOI: 10.1146/ annurev-nutr-021020-025755

[275] Qureshi F, Edhi F, Ozga AT. The impact of delivery mode on the human microbiome: A global perspective. Mako: NSU Undergraduate Student Journal. 2022;**2022**(1):1. Available from: https:// nsuworks.nova.edu/mako/vol2022/ iss1/1/

[276] Cattell M, Lai S, Cerny R, Medeiros DM. A new mechanistic scenario for the origin and evolution of vertebrate cartilage. PLoS ONE. 2011;**6**(7):e22474. DOI: 10.1371/journal. pone.0022474

[277] Wang H-X, Wang Y-P. Gut Microbiota-brain axis. Chinese Medical Journal. 2016;**129**(19):2373-2380. Available from: https://journals.lww. com/00029330-201610050-00016

[278] Cryan JF, O'Mahony SM. The microbiome-gut-brain axis: From bowel to behavior. Neurogastroenterology and Motility. 2011;**23**(3):187-192. Available from: https://onlinelibrary.wiley.com/ doi/10.1111/j.1365-2982.2010.01664.x

[279] Barbara G, Brummer RJ, Delzenne N, Doré J, Ghoeler L, Konsman J, et al. Investigating the crosstalk between the gut microbiota and the host: The gut-brain axis. Consensus Report Warsaw. 2007. Available from: http://citeseerx.ist.psu.edu/viewdoc/dow nload?doi=10.1.1.470.9602&rep=rep1&t ype=pdf

[280] Kinlein SA, Karatsoreos IN. The hypothalamic-pituitary-adrenal axis
